White, Harvey D <br/><br/>
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.  [electronic resource] 

 -  Journal of the American College of Cardiology  Sep 2008 
 - 807-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1558-3597 
<br/><br/><label>Standard No.: </label>10.1016/j.jacc.2008.05.036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angioplasty, Balloon, Coronary<br/>Anticoagulants--adverse effects<br/>Drug Therapy, Combination<br/>Enoxaparin--adverse effects<br/>Female<br/>Fibrinolytic Agents--adverse effects<br/>Heparin--adverse effects<br/>Hirudins--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Peptide Fragments--adverse effects<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Recombinant Proteins--adverse effects<br/>Risk Factors<br/>Time Factors